Le Lézard
Classified in: Health
Subject: PER

Olive Fertility Centre Victoria Welcomes New Fertility Specialist Dr. Riki Dayan


Olive Fertility Centre is pleased to announce that Dr. Riki Dayan MD FRCSC has joined the Olive Fertility Victoria Team. She pursued formal fellowship training in Gynecologic Reproductive Endocrinology and Infertility at McMaster University, and is doubly certified by the Royal College of Physicians and Surgeons of Canada in Obstetrics and Gynecology and in Reproductive Endocrinology and Infertility.

VICTORIA, BC, May 6, 2024 /PRNewswire-PRWeb/ -- Olive Fertility Centre is pleased to announce that Dr. Riki Dayan MD FRCSC has joined the Olive Fertility Victoria Team. "We are delighted to welcome Dr. Dayan to Olive Fertility," says Olive co-director Dr. Niamh Talon. "With her expertise in fertility, her dedication to education and her focus on whole person, patient-centred care, Dr. Dayan is an invaluable addition to the Olive Team."

"With her expertise in fertility, her dedication to education and her focus on whole person, patient-centred care, Dr. Dayan is an invaluable addition to the Olive Team," says Olive co-director Dr. Niamh Talon.

Dr. Dayan (she/her) received her Bachelor of Science (Honours) degree at the University of Victoria. She then went on to complete medical school and Obstetrics and Gynecology residency training at the University of British Columbia (UBC). Having personally experienced infertility and recurrent pregnancy loss, she developed an interest in the field and pursued formal fellowship training in Gynecologic Reproductive Endocrinology and Infertility at McMaster University. She is doubly certified by the Royal College of Physicians and Surgeons of Canada in Obstetrics and Gynecology and in Reproductive Endocrinology and Infertility.

With a personal and professional understanding of the emotional impact of infertility, Dr. Dayan is committed to better understanding how to best support fertility patients on their journey to parenthood. Her areas of research have focused on the role of mindfulness meditation in infertility and the impact of air pollution on fertility. Further, she is committed to medical education through her medical education research, as a member of the Center for Health Education Scholarship and as a Clinical Instructor at UBC.

Dr. Dayan feels immensely privileged to be in this field and to accompany her patients on their fertility journeys. She believes that just as each person is unique, so is each fertility journey. She is grateful for the opportunity to develop personal relationships with her patients and to help them navigate the world of fertility care. In addition, she is excited about the advanced technologies like AI that are emerging and improving outcomes for patients.

"I feel very privileged to be able to work in the field of fertility care. It's one of the most innovative and rapidly changing areas in medicine today. With new technologies that are now available, the chance of achieving a successful pregnancy is extremely high," says Dr. Dayan.

Dr. Dayan is delighted to return to Victoria and serve the community on Vancouver Island. When she is not working, she can be found trail running, meditating, and spending time with her family.

Olive Fertility Centre is of Canada's largest fertility clinics, offering an advanced IVF lab, personal care teams, and innovative programs that include Preimplantation Genetic Testing for Aneuploidy (PGT-A), egg freezing, and prenatal NIPT testing.

Media Contact

Mairi Campbell, Olive Fertility Centre, 1 778-885-5300, [email protected], https://www.olivefertility.com/ 

SOURCE Olive Fertility Centre


These press releases may also interest you

at 00:25
Zai Lab Limited and Innoviva Specialty Therapeutics today announced that China's National Medical Products Administration (NMPA) has approved Zai Lab's New Drug Application (NDA) for XACDURO® (sulbactam-durlobactam) for the treatment of...

19 mai 2024
Frost & Sullivan recently analyzed the hospital industry and noted that operational inefficiencies, workflow interruptions and shortage of skilled healthcare professionals are some key challenges faced by the healthcare industry. Based on its...

19 mai 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

19 mai 2024
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company").  This action, captioned Hope v. agilon health, inc., et...

19 mai 2024
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

19 mai 2024
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...



News published on and distributed by: